2639 Results

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Palomba
    Palomba
  4. Noy
    Noy
  5. Moskowitz
    Moskowitz
  6. Younes
    Younes
  7. Matasar
    Matasar
  8. Moskowitz
    Moskowitz
  9. Yahalom
    Yahalom
  10. Portlock
    Portlock

Groups

  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)
  7. Executive Committee, Center for Hematologic Malignancies (389)
  8. Epidemiology and Biostatistics (363)
  9. GSK Faculty (356)
  10. Department of Pathology and Laboratory Medicine (300)
  1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas
    Correspondence

    Fitzgerald, K. N.; Quesada, A. E.; von Keudell, G.; Raj, S.; Lewis, N. E.; Dogan, A.; Salles, G.; Palomba, M. L.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Overall survival with brentuximab vedotin in stage III or IV Hodgkin's lymphoma
    Journal Article

    Ansell, S. M.; Radford, J.; Connors, J. M.; Długosz-Danecka, M.; Kim, W. S.; Gallamini, A.; Ramchandren, R.; Friedberg, J. W.; Advani, R.; Hutchings, M.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • PI3K inhibitors in haematological malignancies
    Correspondence

    Matasar, M. J.; Hiemeyer, F.; Childs, B. H.; Zinzani, P. L.
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Predictors of major hemorrhage after spleen core biopsy in cancer patients
    Journal Article

    Kunin, H.; Wijetunga, N. A.; Erinjeri, J. P.; Noy, A.; Deipolyi, A. R.
    Journal of Vascular and Interventional Radiology (2022)

    Fulltext@MSK | Save
  • Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
    Research Letter

    Thompson, M. C.; Harrup, R. A.; Coombs, C. C.; Roeker, L. E.; Pu, J. J.; Choi, M. Y.; Barr, P. M.; Allan, J. N.; Šimkovič, M.; Leslie, L.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Primary cutaneous lymphoma: Recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
    Guidelines

    Olsen, E. A.; Whittaker, S.; Willemze, R.; Pinter-Brown, L.; Foss, F.; Geskin, L.; Schwartz, L.; Horwitz, S.; Guitart, J.; Zic, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies
    Meeting Abstract

    Imber, B. S.; Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Alarcon Tomas, A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Vitamin D deficiency is associated with inferior clinical outcomes in patients with large B-cell lymphoma receiving anti-CD19 CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Alarcon Tomas, A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. W.; Dahi, P. B.; Fingrut, W.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Meeting Abstract

    Dahi, P. B.; Geyer, A.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Two-year (yr) follow-up (FU) of Transcend NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) in relapsed or refractory (R/R) large B-cell lymphomas (LBCL)
    Meeting Abstract

    Abramson, J. S.; Palomba, M. L.; Gordon, L. I.; Lunning, M.; Wang, M.; Arnason, J.; Purev, E.; Maloney, D. G.; Andreadis, C.; Sehgal, A. R.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save